These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38134196)

  • 1. Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.
    Miyamoto S; Nishiyama T; Ueno A; Park H; Kanno T; Nakamura N; Ozono S; Aihara K; Takahashi K; Tsuchihashi Y; Ishikane M; Arashiro T; Saito S; Ainai A; Hirata Y; Iida S; Katano H; Tobiume M; Tokunaga K; Fujimoto T; Suzuki M; Nagashima M; Nakagawa H; Narita M; Kato Y; Igari H; Fujita K; Kato T; Hiyama K; Shindou K; Adachi T; Fukushima K; Nakamura-Uchiyama F; Hase R; Yoshimura Y; Yamato M; Nozaki Y; Ohmagari N; Suzuki M; Saito T; Iwami S; Suzuki T
    Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2314808120. PubMed ID: 38134196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
    Martinuzzi E; Benzaquen J; Guerin O; Leroy S; Simon T; Ilie M; Hofman V; Allegra M; Tanga V; Michel E; Boutros J; Maniel C; Sicard A; Glaichenhaus N; Czerkinsky C; Blancou P; Hofman P; Marquette CH
    Clin Infect Dis; 2022 Dec; 75(12):2053-2059. PubMed ID: 35579991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.
    Li D; Calderone R; Nsouli TM; Reznikov E; Bellanti JA
    Allergy Asthma Proc; 2022 Sep; 43(5):419-430. PubMed ID: 36065108
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.
    Ruiz MJ; Siracusano G; Cottignies-Calamarte A; Tudor D; Real F; Zhu A; Pastori C; Capron C; Rosenberg AR; Temperton N; Cantoni D; Liao H; Ternette N; Moine P; Godement M; Geri G; Chiche JD; Annane D; Cramer Bordé E; Lopalco L; Bomsel M
    Front Immunol; 2022; 13():842468. PubMed ID: 36248831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy.
    St Clair LA; Eldesouki RE; Sachithanandham J; Yin A; Fall A; Morris CP; Norton JM; Abdullah O; Dhakal S; Barranta C; Golding H; Bersoff-Matcha SJ; Pilgrim-Grayson C; Berhane L; Cox AL; Burd I; Pekosz A; Mostafa HH; Klein EY; Klein SL
    mSphere; 2024 Mar; 9(3):e0081223. PubMed ID: 38426787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response.
    Takamatsu Y; Omata K; Shimizu Y; Kinoshita-Iwamoto N; Terada M; Suzuki T; Morioka S; Uemura Y; Ohmagari N; Maeda K; Mitsuya H
    Microbiol Spectr; 2022 Dec; 10(6):e0271622. PubMed ID: 36219096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of viral load and antibodies to SARS-CoV-2.
    Sun J; Tang X; Bai R; Liang C; Zeng L; Lin H; Yuan R; Zhou P; Huang X; Xiong Q; Peng J; Cui F; Ke B; Su J; Liu Z; Lu J; Tian J; Sun R; Ke C
    Clin Microbiol Infect; 2020 Dec; 26(12):1690.e1-1690.e4. PubMed ID: 32898715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2.
    Conti MG; Terreri S; Piano Mortari E; Albano C; Natale F; Boscarino G; Zacco G; Palomba P; Cascioli S; Corrente F; Capponi C; Mirabella M; Salinas AF; Marciano A; De Luca F; Pangallo I; Quaranta C; Alteri C; Russo C; Galoppi P; Brunelli R; Perno CF; Terrin G; Carsetti R
    JAMA Netw Open; 2021 Nov; 4(11):e2132563. PubMed ID: 34730817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.
    Fröberg J; Diavatopoulos DA
    Curr Opin Infect Dis; 2021 Jun; 34(3):181-186. PubMed ID: 33899752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract.
    Hu F; Chen F; Ou Z; Fan Q; Tan X; Wang Y; Pan Y; Ke B; Li L; Guan Y; Mo X; Wang J; Wang J; Luo C; Wen X; Li M; Ren P; Ke C; Li J; Lei C; Tang X; Li F
    Cell Mol Immunol; 2020 Nov; 17(11):1119-1125. PubMed ID: 33037400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses.
    Puhach O; Bellon M; Adea K; Bekliz M; Hosszu-Fellous K; Sattonnet P; Hulo N; Kaiser L; Eckerle I; Meyer B
    EBioMedicine; 2023 Dec; 98():104893. PubMed ID: 38035462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
    Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T
    Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2022; 13():995235. PubMed ID: 36172368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection.
    Sheikh-Mohamed S; Isho B; Chao GYC; Zuo M; Cohen C; Lustig Y; Nahass GR; Salomon-Shulman RE; Blacker G; Fazel-Zarandi M; Rathod B; Colwill K; Jamal A; Li Z; de Launay KQ; Takaoka A; Garnham-Takaoka J; Patel A; Fahim C; Paterson A; Li AX; Haq N; Barati S; Gilbert L; Green K; Mozafarihashjin M; Samaan P; Budylowski P; Siqueira WL; Mubareka S; Ostrowski M; Rini JM; Rojas OL; Weissman IL; Tal MC; McGeer A; Regev-Yochay G; Straus S; Gingras AC; Gommerman JL
    Mucosal Immunol; 2022 May; 15(5):799-808. PubMed ID: 35468942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.
    Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X
    Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.
    Bladh O; Aguilera K; Marking U; Kihlgren M; Greilert Norin N; Smed-Sörensen A; Sällberg Chen M; Klingström J; Blom K; Russell MW; Havervall S; Thålin C; Åberg M
    Front Immunol; 2024; 15():1346749. PubMed ID: 38558811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2.
    Ye X; Angelo LS; Nicholson EG; Iwuchukwu OP; Cabral de Rezende W; Rajan A; Aideyan LO; McBride TJ; Bond N; Santarcangelo P; Rayford YJ; Ferlic-Stark L; Fragoso S; Momin Z; Liu H; Truong K; Lopez B; Conner ME; Rice AP; Kimata JT; Avadhanula V; Piedra PA
    Front Immunol; 2021; 12():693462. PubMed ID: 34691016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
    Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
    Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection.
    Sajadi MM; Myers A; Logue J; Saadat S; Shokatpour N; Quinn J; Newman M; Deming M; Rikhtegaran Tehrani Z; Magder LS; Karimi M; Abbasi A; Shlyak M; Baracco L; Frieman MB; Crotty S; Harris AD
    mSphere; 2022 Dec; 7(6):e0027922. PubMed ID: 36321826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.